Dr. Santora joined Kinexum in 2017 after 30-years of experience in clinical pharmaceutical research.
Dr. Santora received his medical education at Emory University in Atlanta, where he also received a PhD in biochemistry. After an Internal Medicine residency, also at Emory, he completed an Endocrinology and Metabolism fellowship at the NIH Clinical Center in Bethesda, MD. His interest in pharmaceutical research was sparked by two-year appointment as a Medical Officer at the US FDA. After his tenure at the FDA, he became an Assistant Professor of Medicine the Division of Endocrinology, Metabolism and Hypertension at Wayne State University Medical School for 3 years before joining Merck Research Laboratories to work on the Fosamax® development program at the start of phase 2. Dr. Santora became the lead Clinical Research physician responsible for many components of Fosamax development. During his work with Fosamax he:
Dr. Santora remains active as a physician at Rutgers Robert Wood Johnson Medical School in New Brunswick, NJ, involved in both education and patient care focusing on osteoporosis and other disorders of calcium and mineral metabolism. He is a member of the Endocrine Society, the American Society for Bone and Mineral Research, American Association of Clinical Endocrinologists and a Fellow of the American College of Endocrinology. He is certified in Internal Medicine and Endocrinology & Metabolism.
Ramachandra (Ram) G. Naik, M.D.
Biostatistics
Regulatory Science & Innovation; Biomedical Advanced R&D
EU Regulatory
Clinical Operations/Project Management
Julie Waltz Gerlach, B.S.N., M.P.H., R.A.C.
Health Policy Development
CMC, Formulation/Process Development & Sourcing
Medical Device
Eric Kolb
Melissa Thompson
QA/QC
Medical Writing/Electronic Submissions
Kristi Hultberg, B.S.
Botanicals
Government Relations and Public Affairs
Defense & National Security Practice
Commercialization and Business & Corporate Strategy
Kinexum Associates
Elijah Abass